Definitive Contract #75F40126C00123

Definitive Contract Awarded to MedTech Innovator for Medical Device Solutions

This definitive contract has been awarded to MedTech Innovator, a company specializing in supporting medical device innovation and market entry challenges. The contract focuses on addressing the high failure rates of medical device companies, emphasizing that FDA market authorization alone is often insufficient for commercial success. The work involves extensive evaluation and support services for medical device innovators to improve market outcomes. This award holds significant importance for the healthcare and medical technology industries by aiming to reduce device failure rates and enhance public health impact through improved innovation pathways. The scope of work includes delivering analytical and advisory services based on 13 years of data involving over 14,000 companies. This contract was competitively awarded and will be performed over a multi-year period with operations based in Los Angeles, California. No contract vehicle or subcontractor information is provided, and there are no details on previous contracts or solicitation specifics.

Description

EO 14398 - MEDICAL DEVICE COMPANIES FAIL AT RATES UP TO 75% (FALAHAT & FALAHAT, 2024). ACROSS 13 YEARS OF EVALUATING 14,000+ COMPANIES, MTI HAS DOCUMENTED A CONSISTENT CAUSE: FDA MARKET AUTHORIZATION IS NECESSARY BUT RARELY SUFFICIENT. INNOVATORS

View original record